GE Healthcare collaborates with Sophia Genetics

By The Science Advisory Board staff writers

July 6, 2021 -- GE Healthcare and Sophia Genetics announced that they are collaborating to better target and match treatments to each patient's genomic profile and cancer type.

The companies aim to develop new artificial intelligence-powered analytics and workflow solutions to serve both the clinical and biopharma markets. They will combine data from the GE Healthcare Edison platform and the Sophia DDM cloud-based platform. The Edison platform integrates and assimilates data and applies analytics and algorithms to generate clinical, operational, and financial insights. The DDM software-as-a-service provides analytical genomic insights.

The goal of the collaboration is to generate actionable insights for clinicians and researchers from complex multimodal datasets.

Could more sugar-based drugs be on the way?
Researchers from Denmark have developed a new technique to characterize complex sugar molecules in exquisite detail never before achieved, according to...
GE & Advanced Solutions announce strategic collaboration
On Sunday, December 8, GE Healthcare Life Sciences and Advanced Solutions Life Sciences announced a strategic partnership for their integrated IN Cell...
GE launches super-resolution microscope
GE Healthcare announced the newest addition to their collection of microscopes, the DeltaVision OMX Flex super-solution microscope, on September 18. EDGE...

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter